MADx Round Table Registration
Nice to meet you - we are MADx!
You might not have heard about us yet, and that's okay! Here is a little bit about us, so you know who we are and what we stand for:
We are MADx, a medtech company founded in 2016 and based in Vienna, Austria. Our focus? Developing and producing revolutionary tests for IgE mediated allergies. As of today, our solutions are trusted by labs, clinics, hospitals, and allergy centres in over 90 countries.
Until recently, our products were offered in the UK through a distribution partner. As of May 2025, MADx has taken over all sales and services directly, with a dedicated team now on the ground in the UK. Our flagship product, ALEX, is the world's most comprehensive allergy blood test.
We are excited to connect with you and are looking forward to the round table at BSACI 2025!
MADx Round Table, Oct 17
As part of our commitment to the UK market, we will be exhibiting at the BSACI Conference in Wales (16 - 18 October 2025) at booth 8.
Join the round table on Oct 17 at 4pm and discuss the following topics over one hour with us and our partners.
- When does multiplex testing offer clinical added value compared to prick or singleplex tests?
- How can the ‘flood of information’ (sensitisation vs. allergy) be classified in a clinically meaningful way?
- Are there cases in which multiplex testing has actually influenced a treatment decision?
- What is the advantage over purely hypothesis-driven diagnostics?
- What could an integrated interpretation aid look like?
 "20250731_RZ_MADx_BSACI_Conference 2025_Landing Page Sujet_1080x1080px20250731_RZ_MADx_BSACI_Conference 2025_Landing Page Sujet_1080x1080px")
Register here for the MADx Round Table at BSACI
Registration for the BSACI Allergy & Clinical Immunology Conference required to attend.